open image in gallery Semaglutide - the active ingredient in Ozempic and other Novo products - has been linked to eye conditions (Getty/iStock) In subgroup analyses, the elevated risk for NAION ...

A new study adds to evidence to suggest the main ingredient in Novo Nordisk’s injectable drug for type 2 diabetes may increase patients’ risk for a dangerous eye condition. The findings about ...

The researchers tracked nearly 175,000 patients with diabetes who received semaglutide -- the active ingredient in Ozempic ... The higher risk of developing the sight-threatening eye problem ...

A new study adds to evidence to suggest the main ingredient in Novo Nordisk’s injectable drug for type 2 diabetes may increase patients’ risk for a dangerous eye condition ... the active ingredient in ...

A YOUNG woman has revealed that she lost five and a half stone after using fat jabs for nine months. Bethany Diana, 27, ...

Using Ozempic with insulin may increase your risk of this side effect ... cause worsening symptoms of diabetic retinopathy, an eye condition related to diabetes. If you have diabetic retinopathy ...